Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Thermo Fisher Scientific Inc. (NYSE:TMO)

Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Thermo Fisher Scientific Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Short-term obligations and current maturities of long-term obligations 676  1,271  2,135  1,256  1,053 
Accounts payable 1,920  1,615  1,428  926  822 
Accrued payroll and employee benefits 1,010  982  918  709  598 
Contract liabilities 916  809  —  —  — 
Deferred revenue —  —  719  486  318 
Other accrued expenses 1,675  1,470  1,848  1,490  1,356 
Current liabilities 6,197  6,147  7,048  4,866  4,147 
Deferred income taxes 2,192  2,265  2,766  2,557  2,623 
Other long-term liabilities 3,241  2,515  2,569  1,573  1,295 
Long-term obligations, excluding current maturities 17,076  17,719  18,873  15,372  11,474 
Long-term liabilities 22,509  22,499  24,208  19,502  15,392 
Total liabilities 28,706  28,646  31,256  24,368  19,539 
Preferred stock, $100 par value; none issued —  —  —  —  — 
Common stock, $1 par value 434  432  428  415  412 
Capital in excess of par value 15,064  14,621  14,177  12,140  11,801 
Retained earnings 22,092  18,696  15,914  13,927  12,142 
Treasury stock at cost (5,236) (3,665) (3,103) (2,306) (1,008)
Accumulated other comprehensive items (2,679) (2,498) (2,003) (2,636) (1,997)
Shareholders’ equity 29,675  27,586  25,413  21,539  21,350 
Total liabilities and shareholders’ equity 58,381  56,232  56,669  45,908  40,889 

Based on: 10-K (filing date: 2020-02-26), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Thermo Fisher Scientific Inc.’s current liabilities decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Thermo Fisher Scientific Inc.’s long-term liabilities decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Thermo Fisher Scientific Inc.’s total liabilities decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Thermo Fisher Scientific Inc.’s shareholders’ equity increased from 2017 to 2018 and from 2018 to 2019.